Dentsply Sirona stock (US9839191015): Q1 earnings miss and updated FY guidance

Dentsply Sirona reported Q1 2026 EPS of $0.27, missing estimates by $0.01, with revenue up 0.1% to $880 million. The company updated its full-year guidance amid a trailing EPS of -$3.15.

Dentsply Sirona released its Q1 2026 earnings on May 5, 2026, posting adjusted EPS of $0.27, which fell short of the $0.28 consensus estimate by $0.01. Quarterly revenue increased 0.1% year-over-year to $880 million, surpassing expectations of $841.80 million, MarketBeat as of May 2026. The company also updated its FY 2026 guidance to EPS of $1.40-$1.50 versus consensus $1.43, and revenue of $3.5-$3.6 billion against $3.6 billion expected.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Dentsply Sirona Inc.
• Sector/industry: Dental Equipment & Technology
• Headquarters/country: United States
• Core markets: North America, Europe
• Key revenue drivers: Dental consumables, equipment
• Home exchange/listing venue: Nasdaq (XRAY)
• Trading currency: USD

Dentsply Sirona: core business model

Dentsply Sirona operates as a leading provider of dental products and technologies worldwide. The company offers a broad portfolio including consumables, equipment, and digital solutions for dental professionals. Its business spans preventive, restorative, and orthodontic care, serving dentists, labs, and specialists globally. With a focus on innovation, Dentsply Sirona invests in R&D to develop tools like CAD/CAM systems and imaging devices.

Main revenue and product drivers for Dentsply Sirona

Revenue primarily comes from consumables such as composites, sealants, and endodontics, which provide recurring sales. Equipment sales, including chairs, handpieces, and scanners, contribute significantly alongside digital dentistry solutions. In Q1 2026, revenue reached $880 million, up slightly year-over-year, driven by strength in these core areas, MarketBeat as of May 2026. The company reported a trailing EPS of -$3.15 over the last four quarters, reflecting profitability challenges.

Industry trends and competitive position

The dental equipment sector benefits from rising demand for cosmetic and digital dentistry in the US, where aging populations drive procedure volumes. Dentsply Sirona holds a strong position with its integrated portfolio, competing against players like Align Technology and Henry Schein. US investors track the firm for its exposure to elective dental spending, which ties to economic health.

Why Dentsply Sirona matters for US investors

Listed on Nasdaq, Dentsply Sirona offers US investors access to a global dental leader with substantial North American revenue. The sector's stability amid healthcare trends makes it relevant, especially as digital adoption grows in US practices. Recent earnings highlight ongoing recovery efforts post-restructuring.

Conclusion

Dentsply Sirona's Q1 results showed revenue beats but an EPS miss, with updated FY guidance signaling cautious optimism. The stock traded around $10.44 recently amid market volatility, TradingView as of May 2026. Investors monitor execution on guidance and sector trends for signs of turnaround in this key US-listed dental play.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.